Is cyproheptadine effective in the treatment of subjects with epidermolysis bullosa simplex-Dowling-Meara?

被引：11
作者：
NeufeldKaiser, W
Sybert, VP
机构：
[1] Division of Dermatology, Children's Hosp./Medical Center, Seattle, WA 98105
来源：
ARCHIVES OF DERMATOLOGY | 1997年 / 133卷 / 02期
关键词：
D O I：
10.1001/archderm.133.2.251
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：251 / 252
页数：2
相关论文
共 5 条
[1]  
BONNETBLANC JM, 1986, LANCET, V1, P1327
[2]  
*MED EC DAT PROD C, 1994, PHYS DESK REF, P1513
[3]   A KERATIN-14 MUTATIONAL HOT-SPOT FOR EPIDERMOLYSIS-BULLOSA SIMPLEX, DOWLING-MEARA - IMPLICATIONS FOR DIAGNOSIS [J].
STEPHENS, K ;
SYBERT, VP ;
WIJSMAN, EM ;
EHRLICH, P ;
SPENCER, A .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 101 (02) :240-243
[4]   POSITIVE RESPONSE TO 5HT-2 ANTAGONISTS IN A FAMILY AFFECTED BY EPIDERMOLYSIS-BULLOSA DOWLING-MEARA TYPE [J].
TADINI, G ;
ERMACORA, E ;
CAMBIAGHI, S ;
BRUSASCO, A ;
CAVALLI, R .
DERMATOLOGY, 1993, 186 (01) :80-80
[5]  
Xin H. B., 1993, Acta Pharmaceutica Sinica, V28, P92
1